95 related articles for article (PubMed ID: 6655831)
1. [Susceptibility of clinical isolates in pediatrics to cefpiramide].
Deguchi K
Jpn J Antibiot; 1983 Aug; 36(8):2129-34. PubMed ID: 6655831
[TBL] [Abstract][Full Text] [Related]
2. [Experimental and clinical evaluation of cefpiramide in pediatrics].
Iwai N; Mizoguchi F; Sasaki A; Taneda Y; Nakamura H
Jpn J Antibiot; 1983 Aug; 36(8):2242-60. PubMed ID: 6655844
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical evaluation of cefpiramide in pediatrics].
Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Ida H; Mochizuki H; Hori M
Jpn J Antibiot; 1983 Aug; 36(8):2207-27. PubMed ID: 6655842
[TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical studies of cefoperazone in children (author's transl)].
Yamaguchi H; Nishikawa K; Ogawa A; Kuno K; Kondo K
Jpn J Antibiot; 1980 Aug; 33(8):841-51. PubMed ID: 6451730
[TBL] [Abstract][Full Text] [Related]
6. [Fundamental and clinical studies of cefpiramide in the field of obstetrics and gynecology].
Ninomiya K; Ohbayashi F; Hasegawa Y
Jpn J Antibiot; 1985 Aug; 38(8):2360-6. PubMed ID: 4079009
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory and clinical studies of cefoperazone in children (author's transl)].
Iwai N; Sasaki A; Miyazu M; Osuga T; Inokuma K
Jpn J Antibiot; 1980 Sep; 33(9):871-90. PubMed ID: 6452536
[TBL] [Abstract][Full Text] [Related]
8. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of cefoperazone].
Watanabe Y; Minami S; Yotsuji A; Araki H; Yasuda T; Saikawa I
Jpn J Antibiot; 1983 Dec; 36(12):3437-43. PubMed ID: 6609251
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activity of cefpiramide to fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1991 Aug; 44(8):820-38. PubMed ID: 1920808
[TBL] [Abstract][Full Text] [Related]
12. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
13. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
[TBL] [Abstract][Full Text] [Related]
15. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of resistance to cephalosporins.
Atkinson BA
Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
19. [Clinical experience with cefpiramide in pediatrics].
Obara T; Kudo K; Watanabe A
Jpn J Antibiot; 1983 Aug; 36(8):2142-6. PubMed ID: 6655833
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
